Brooks Laboratories Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 347

Employees

  • Stock Symbol
  • 533543

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.68
  • (As of Friday Closing)

Brooks Laboratories General Information

Description

Brooks Laboratories Ltd is engaged in pharmaceutical activities. The company has two reportable segments Manufacturing- comprising the company's own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients and intermediaries; and Trading- comprising principal-to-principal trading activities in pharmaceutical products, ingredients and intermediaries. The company generates majority of revenue from Manufacturing segment. Its products are Liquid Injection Ampoules, Liquid Injection Vials, Dry Powder Injection Vials, Lyophilized Injections, Eye/Ear Drops, Nasal Drops, Tablets, Dry Powder Syrup, Injection, etc.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 201, The Summit Business Park
  • Behind Guru Nanak Petrol Pump, Off. Andheri Kurla Road, Andheri East
  • Mumbai, 400093
  • India
+91 022
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • 201, The Summit Business Park
  • Behind Guru Nanak Petrol Pump, Off. Andheri Kurla Road, Andheri East
  • Mumbai, 400093
  • India
+91 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brooks Laboratories Stock Performance

As of 13-Nov-2026, Brooks Laboratories’s stock price is $0.68. Its current market cap is $20.1M with 29.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.68 $0.70 $0.39 - $1.25 $20.1M 29.5M 12.4K $0.05

Brooks Laboratories Financials Summary

As of 30-Jun-2026, Brooks Laboratories has a trailing 12-month revenue of $9.2M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 22,063 12,288 37,810 29,602
Revenue 9,180 9,662 9,720 9,544
EBITDA 1,718 3,023 (895) (2,071)
Net Income 1,458 2,782 (1,179) (2,367)
Total Assets 15,704 14,461 10,846
Total Debt 0 903 886 677
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Brooks Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Brooks Laboratories‘s full profile, request access.

Request a free trial

Brooks Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brooks Laboratories Investments & Acquisitions (3)

Brooks Laboratories’s most recent deal was a Merger/Acquisition with SteriBrooks Penems. The deal was made on 18-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SteriBrooks Penems 18-Sep-2020 Merger/Acquisition Other Commercial Services
Brooks Steriscience 04-Sep-2020 Joint Venture Drug Discovery
SteriBrooks Penems 18-Jun-2020 Joint Venture Other Commercial Services
To view Brooks Laboratories’s complete investments and acquisitions history, request access »

Brooks Laboratories ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Brooks Laboratories’s complete esg history, request access »

Brooks Laboratories Exits (1)

Brooks Laboratories’s most recent exit was on 04-Sep-2020 from Brooks Steriscience. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Brooks Steriscience 04-Sep-2020 Completed
  • 2 buyers
To view Brooks Laboratories’s complete exits history, request access »

Brooks Laboratories Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
SteriBrooks Penems Bangalore, India 2020

Brooks Laboratories FAQs

  • When was Brooks Laboratories founded?

    Brooks Laboratories was founded in 2002.

  • Where is Brooks Laboratories headquartered?

    Brooks Laboratories is headquartered in Mumbai, India.

  • What is the size of Brooks Laboratories?

    Brooks Laboratories has 347 total employees.

  • What industry is Brooks Laboratories in?

    Brooks Laboratories’s primary industry is Pharmaceuticals.

  • Is Brooks Laboratories a private or public company?

    Brooks Laboratories is a Public company.

  • What is Brooks Laboratories’s stock symbol?

    The ticker symbol for Brooks Laboratories is 533543.

  • What is the current stock price of Brooks Laboratories?

    As of 13-Nov-2026 the stock price of Brooks Laboratories is $0.68.

  • What is the current market cap of Brooks Laboratories?

    The current market capitalization of Brooks Laboratories is $20.1M.

  • What is Brooks Laboratories’s current revenue?

    The trailing twelve month revenue for Brooks Laboratories is $9.2M.

  • What is Brooks Laboratories’s annual earnings per share (EPS)?

    Brooks Laboratories’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process